Skip to main content
SpringerLink
Log in

Endoscopic Surveillance in Long-standing Colitis

  • Endoscopy (P Siersema, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

There is a relative increase in the risk of colon cancer in patients with inflammatory bowel disease (IBD) affecting the colon, and endoscopic surveillance is advocated to mitigate this risk. The current standard practice is to survey this high-risk patient population using colonoscopy. Chromoendoscopy with targeted biopsies has emerged as the colonoscopy modality recommended by the major societies to optimize dysplasia detection. Studies over the past year support the improved yield from targeted as compared to random biopsies and improved dysplasia detection from chromoendoscopy as compared to white light endoscopy. Ongoing efforts should focus on the implementation of chromoendoscopy as the primary modality for colorectal cancer surveillance in IBD. Our review will describe current status and provide an update on the recent literature on surveillance colonoscopy in patients with IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100(12):2724–9.

    Article  PubMed  Google Scholar 

  2. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10(6):639–45.

    Article  PubMed  Google Scholar 

  3. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372(15):1441–52.

    Article  CAS  PubMed  Google Scholar 

  4. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323(18):1228–33.

    Article  CAS  PubMed  Google Scholar 

  5. Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19(4):789–99.

    Article  PubMed  Google Scholar 

  6. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):738–45.

    Article  PubMed  Google Scholar 

  7. American Society for Gastrointestinal Endoscopy Standards of Practice C, Shergill AK, Lightdale JR, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81(5):1101–21. e1101–1113

  8. Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982–1018.

    Article  PubMed  Google Scholar 

  9. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103(5):1611–20.

    Article  CAS  PubMed  Google Scholar 

  10. Chiorean MV, Helper DJ, Saxena R, et al. Targeted biopsies using chromoendsocopy can replace random biopsies in pateints with IBD at high risk for colorectal neoplasia. Gastroenterol. 2012;142(supp1):S-339.

    Article  Google Scholar 

  11. Gunther U, Kusch D, Heller F, et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Color Dis. 2011;26(5):667–72.

    Article  Google Scholar 

  12. Hlavaty T, Huorka M, Koller T, et al. Colorectal cancer screening in patients with ulcerative and Crohn’s colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy. Eur J Gastroenterol Hepatol. 2011;23(8):680–9.

    Article  PubMed  Google Scholar 

  13. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124(4):880–8.

    Article  PubMed  Google Scholar 

  14. • Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology. 2007;132(3):874–82. Randomized clinical trial of chromoendoscopy with endomicroscopy versus conventional colonoscopy, showing an increase in dysplasia detection with chromoendoscopy with endomicroscopy.

    Article  PubMed  Google Scholar 

  15. Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008;103(9):2342–9.

    Article  PubMed  Google Scholar 

  16. Matsumoto T, Nakamura S, Jo Y, Yao T, Iida M. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol. 2003;98(8):1827–33.

    Article  PubMed  Google Scholar 

  17. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53(2):256–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Picco MF, Pasha S, Leighton JA, et al. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm Bowel Dis. 2013;19(9):1913–20.

    PubMed  Google Scholar 

  19. Leong RW, Ooi M, Corte C, et al. Full-spectrum endoscopy improves surveillance for dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2017.

  20. • Carballal S, Maisterra S, Lopez-Serrano A, et al. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut. 2016. Prospective clinical trial of segmental white light endoscopy followed by chromoendoscopy showing an increase yield in dysplasia with chromoendoscopy.

  21. Gasia MF, Ghosh S, Panaccione R, et al. Targeted biopsies identify larger proportions of patients with colonic neoplasia undergoing high-definition colonoscopy, dye chromoendoscopy, or electronic virtual chromoendoscopy. Clin Gastroenterol Hepatol. 2016;14(5):704–12. e704

  22. Rubin D, Cleveland NK, Rodriguez DM. Outcomes of colitis-associated dysplasia after referral from the community to a tertiary care center. Gastrointest Endosc. 2016;83(5S):AB439.

    Article  Google Scholar 

  23. Marion JF, Waye JD, Israel Y, et al. Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis. Clin Gastroenterol Hepatol. 2016;14(5):713–9.

    Article  PubMed  Google Scholar 

  24. Deepak P, Hanson GJ, Fletcher JG, et al. Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy. Gastrointest Endosc. 2016;83(5):1005–12.

    Article  PubMed  Google Scholar 

  25. • Choi CH, Ignjatovic-Wilson A, Askari A, et al. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer. Am J Gastroenterol. 2015;110(10):1461–1471. quiz 1472. A retrospective study identified risk factors for progression to high grade dysplasia: lesions that were endoscopically invisible, lesions ≥1 cm, and prior biopsies that were indefinite for dysplasia.

  26. Iacucci M, Gasia MF, Olusey A, et al. Final results of a randomised study comparing high-definition colonoscopy alone wiht high-definition dye spraying and electronic virtual chromoendoscopy using iSCAN for detection of colonic neoplastic lesions during IBD surveillance colonoscopy. ECCO Congress. 2016.

  27. Park SJ, Kim H.S.; Yang, D.; et al. High definition chromoendoscopy with water-jet versus high definition white light endoscopy in the detection of dysplasia in long standing ulcerative colitis: a multicenter prospective randomized controlled study. International Meeting on Intestinal Diseases in Conjunction with the Annual Congress of the Korean Association for the Study of Intestinal Diseases. 2016(FP2-1).

  28. Mohammed N, Kant P, Abid F, et al. High definition white light endoscopy (HDWLE) versus high definition with chromoendoscopy (HDCE) in the detection of dysplasia in long standing ulcerative colitis: a randomized controlled trial. Gastrointest Endosc. 2015;81(5S):A446.

    Google Scholar 

  29. Iannone A, Ruospo M, Wong G, et al. Chromoendoscopy for surveillance in ulcerative colitis and Crohn’s disease: a systematic review of randomized trials. Clin Gastroenterol Hepatol 2016.

  30. Dekker E, van den Broek FJ, Reitsma JB, et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy. 2007;39(3):216–21.

    Article  CAS  PubMed  Google Scholar 

  31. Ignjatovic A, East JE, Subramanian V, et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol. 2012;107(6):885–90.

    Article  PubMed  Google Scholar 

  32. van den Broek FJ, Fockens P, van Eeden S, et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy. 2011;43(2):108–15.

    Article  PubMed  Google Scholar 

  33. Ten Hove JR, Mooiweer E, van der Meulen de Jong AE, et al. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Endoscopy 2016.

  34. Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25(6):657–68.

    Article  CAS  PubMed  Google Scholar 

  35. • Rutter MD, Saunders BP, Wilkinson KH, Kamm MA, Williams CB, Forbes A. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc. 2004;60(3):334–9. Prospective cohort study showing that most colonic lesions can be identified with chromoendoscopy.

    Article  PubMed  Google Scholar 

  36. • Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81(3):489–501 e426. SCENIC international consensus statement guiding surveillance and management of dysplasia in the setting of inflammatory bowel disease.

    Article  PubMed  Google Scholar 

  37. Rutter MD. Surveillance programmes for neoplasia in colitis. J Gastroenterol. 2011;46(Suppl 1):1–5.

    Article  PubMed  Google Scholar 

  38. Bopanna S, Kedia S, Ahuja V. A low-cost method for chromoendoscopy for surveillance in ulcerative colitis. Indian J Gastroenterol. 2016;35(6):482–5.

    Article  PubMed  Google Scholar 

  39. • Watanabe T, Ajioka Y, Mitsuyama K, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology. 2016;151(6):1122–30. Randomized controlled study of surveillance in ulcerative colitis showing that the neoplasia yield from targeted biopsies is greater than random biopsies.

    Article  PubMed  Google Scholar 

  40. Moussata D, Allez M, Cazals-Hatem D, et al. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2017.

  41. Sanduleanu S, Kaltenbach T, Barkun A, et al. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016;83(1):213–22.

    Article  PubMed  Google Scholar 

  42. Konijeti GG, Shrime MG, Ananthakrishnan AN, Chan AT. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc. 2014;79(3):455–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA

    Brigid S. Boland MD

  2. San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA

    Amandeep Shergill MD, MS & Tonya Kaltenbach MD, MAS

  3. Division of Gastroenterology, Department of Medicine, University of California, San Francisco, CA, USA

    Amandeep Shergill MD, MS & Tonya Kaltenbach MD, MAS

Authors
  1. Brigid S. Boland MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amandeep Shergill MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tonya Kaltenbach MD, MAS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tonya Kaltenbach MD, MAS.

Ethics declarations

Conflict of Interest

Brigid S. Boland has received consulting fees from Abbvie and has received research grants from Takeda and Janssen.

Amandeep Shergill has received a research grant from Pentax.

Tonya Kaltenbach has received consulting fees from Olympus.

BSB is supported by a CCFA CDA and UCSD KL2 (1KL2TR001444).

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Endoscopy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boland, B.S., Shergill, A. & Kaltenbach, T. Endoscopic Surveillance in Long-standing Colitis. Curr Treat Options Gastro 15, 429–439 (2017). https://doi.org/10.1007/s11938-017-0141-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-017-0141-3

Keywords

Search

Navigation